Company Profiles

driven by the PitchBook Platform

Ra Pharmaceuticals

Description

Developer of drugs based on intracellular protein-protein interactions. The company is developing a new class of drugs, cyclomimetics, with the diversity and specificity of antibodies, coupled with the oral bioavailability of small molecules.

2008

Founded

PUBLIC

Status

11-50

Employees

IPO

Latest Deal Type

$91.6M

Latest Deal Amount

$85.5M

Total Amount Raised

Description

Developer of drugs based on intracellular protein-protein interactions. The company is developing a new class of drugs, cyclomimetics, with the diversity and specificity of antibodies, coupled with the oral bioavailability of small molecules.

Website:

www.rapharma.com

Ownership Status

Publicly held

Financing Status

Formerly VC-Backed

Primary Industry

Drug Discovery

Other Industries

Pharmaceuticals

Primary Office

87 Cambridge Park Drive Cambridge, MA 02140United States +1 (617) 401-4060
Request a free trial to the PitchBook Platform
You're viewing a free company profile from the PitchBook Platform. To explore Ra Pharmaceuticals's full profile, request a free trial.

Ra Pharmaceuticals Valuation and Funding

Request access
Deal TypeDateAmountRaised to DatePost-ValStatusStage

Ra Pharmaceuticals Cap Table

Stock# of Shares
Authorized
Par ValueDividend Rate (%)Original
Issue Price
LiquidationLiquidation
Pref. Multiple
Conversion
Price
% Owned

Ra Pharmaceuticals Executive Team (7)

NameTitleBoard
Seat
Contact
Info
David LubnerChief Financial Officer & Executive Vice President, Operations
Simon Read Ph.DChief Scientific Officer
Kerry BlackExecutive Director, Operations
Alonso Ricardo Ph.DSenior Vice President of Research & Development
Richard Fahrner Ph.DVice President of Pharmaceutical Development
David Lubner Chief Financial Officer & Executive Vice President, Operations
Simon Read Ph.D Chief Scientific Officer
Kerry Black Executive Director, Operations
Alonso Ricardo Ph.D Senior Vice President of Research & Development
Richard Fahrner Ph.D Vice President of Pharmaceutical Development

Ra Pharmaceuticals Board Members (3)

NameRepresentingRoleSinceContact
Info
Edward MathersNew Enterprise AssociatesPartner000 0000
Robert Heft Ph.DSelfBoard Member000 0000
Timothy PearsonSelfBoard Member000 0000
Edward Mathers Partner New Enterprise Associates
Robert Heft Ph.D Board Member Self
Timothy Pearson Board Member Self
Request full access to PitchBook